Efficacy of Music Therapy and Digital Music Rehabilitation in Dementia
Launched by UNIVERSITY OF HELSINKI · Aug 26, 2022
Trial Information
Current as of October 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating how effective music therapy and digital music rehabilitation can be for people with dementia. The study aims to see if these types of music programs can help improve the well-being of patients living at home or in care homes. It is currently looking for participants who are 60 years or older, speak Finnish, and have been diagnosed with mild to severe dementia. They should also be in stable health and able to participate in the activities.
If you or a loved one is eligible and decides to join, you can expect to engage in music sessions designed to improve mood and cognitive function. The trial will carefully assess how these music therapies impact your quality of life. It’s important to note that individuals with serious mental health issues or significant hearing or vision problems are not eligible to participate. This study could provide valuable insights into how music can support those living with dementia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed dementia (according to International Classification of Diseases \[ICD\] criteria), which is mild \[Clinical Dementia Rating (CDR) score: 0.5-1, Global Deterioration Scale (GDS) score: 3-4\], moderate (CDR: 2, GDS: 4-6), or severe (CDR: 3, GDS: 6-7) dementia
- • Age ≥ 60 years
- • Finnish-speaking (or bilingual; the study is performed in Finnish)
- • Stable physical and somatic condition (no major changes in psychotropic medication during the last 3 months)
- • Physically and cognitively able to take part in the intervention and assessments.
- Exclusion Criteria:
- • Prior severe psychiatric illness or substance abuse
- • Major hearing or visual impairment
About University Of Helsinki
The University of Helsinki, a prestigious institution in Finland, is dedicated to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university engages in cutting-edge studies that aim to improve patient outcomes and contribute to the global knowledge base in medicine. Its commitment to ethical standards and rigorous methodology ensures the integrity and reliability of its clinical research initiatives, making it a key player in the development of novel therapeutic strategies and healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Helsinki, Finland
Helsinki, Finland
Patients applied
Trial Officials
Teppo Särkämö, PhD
Principal Investigator
University of Helsinki
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials